Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder
2007

Effects of High-Dose EPA/DHA on Children with ADHD

Sample size: 9 publication Evidence: moderate

Author Information

Author(s): Sorgi Paul J, Hallowell Edward M, Hutchins Heather L, Sears Barry

Primary Institution: Hallowell Center

Hypothesis

Insufficient levels of omega-3 fatty acids or lack of sufficient reduction of the AA:EPA ratio may explain inconsistent findings in previous studies on ADHD.

Conclusion

High-dose EPA/DHA supplementation may improve behavior in children with ADHD.

Supporting Evidence

  • Supplementation resulted in significant increases in EPA and DHA levels.
  • The AA:EPA ratio decreased significantly from 20.78 to 5.95.
  • Behavioral improvements were reported by a psychiatrist blind to dosage adjustments.
  • Significant correlation between AA:EPA ratio reduction and severity of illness scores.

Takeaway

Giving kids with ADHD a special fish oil can help them behave better.

Methodology

An eight-week open-label pilot study with nine children aged 8-16 receiving high-dose EPA/DHA supplementation.

Potential Biases

Potential bias due to lack of blinding for dosage adjustments and participant compliance.

Limitations

No placebo group, dietary intake not monitored, and dosage adjustments based on AA:EPA ratio may confound results.

Participant Demographics

Nine children aged 8-16, predominantly boys (67%), all diagnosed with ADHD.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1475-2891-6-16

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication